Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
China Shineway Pharmaceutical Group Limited (HK:2877)
HKEX:2877
China Shineway Pharmaceutical Group Limited (2877) Stock Price & Analysis
0 Followers
2877 Stock Chart & Stats
Day’s RangeHK$0 - HK$0
52-Week RangeHK$6.23 - HK$10.20
Previous CloseHK$7.69
Volume1.04M
Average Volume (3M)716.00K
Market Cap
HK$5.81B
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)5.4
Beta0.58
Next Earnings
Aug 30, 2024EPS EstimateN/A
Last Dividend Ex-Date
Apr 29, 2024Dividend Yield7.53%
Share Statistics
EPS (TTM)1.42
Shares Outstanding827,000,000
10 Day Avg. Volume477,500
30 Day Avg. Volume715,995
Standard Deviation0.11
R-Squared0.15
Alpha-0.00623
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
China Shineway Pharmaceutical Group Limited News
PremiumCompany Announcements
China Shineway Shareholders Approve Key ResolutionsOptions Prices
Currently, No data available
---
Ownership Overview
0.00%
Insiders
1.71% Mutual Funds
1.78% Other Institutional Investors
96.51% Public Companies and
Individual Investors
2877 FAQ
What was China Shineway Pharmaceutical Group Limited’s price range in the past 12 months?
China Shineway Pharmaceutical Group Limited lowest stock price was HK$6.23 and its highest was HK$10.20 in the past 12 months.
What is China Shineway Pharmaceutical Group Limited’s market cap?
Currently, no data Available
When is China Shineway Pharmaceutical Group Limited’s upcoming earnings report date?
China Shineway Pharmaceutical Group Limited’s upcoming earnings report date is Aug 30, 2024 which is in 60 days.
How were China Shineway Pharmaceutical Group Limited’s earnings last quarter?
China Shineway Pharmaceutical Group Limited released its earnings results on Mar 28, 2024. The company reported HK$0.68 earnings per share for the quarter, beating the consensus estimate of N/A by HK$0.68.
Is China Shineway Pharmaceutical Group Limited overvalued?
According to Wall Street analysts China Shineway Pharmaceutical Group Limited’s price is currently Overvalued.
Does China Shineway Pharmaceutical Group Limited pay dividends?
China Shineway Pharmaceutical Group Limited pays a Notavailable dividend of HK$0.46 which represents an annual dividend yield of 7.53%. See more information on China Shineway Pharmaceutical Group Limited dividends here
What is China Shineway Pharmaceutical Group Limited’s EPS estimate?
China Shineway Pharmaceutical Group Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does China Shineway Pharmaceutical Group Limited have?
China Shineway Pharmaceutical Group Limited has 827,000,000 shares outstanding.
What happened to China Shineway Pharmaceutical Group Limited’s price movement after its last earnings report?
China Shineway Pharmaceutical Group Limited reported an EPS of HK$0.68 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -2.011%.
Which hedge fund is a major shareholder of China Shineway Pharmaceutical Group Limited?
Currently, no hedge funds are holding shares in HK:2877
---
China Shineway Pharmaceutical Group Limited Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
-6.26%
12-Months-Change
Fundamentals
Return on Equity
14.38%
Trailing 12-Months
Asset Growth
14.05%
Trailing 12-Months
Company Description
China Shineway Pharmaceutical Group Limited
China Shineway Pharmaceutical Group Ltd is an investment holding company in the People's Republic of China. Principally, it is engaged in the research, development, manufacturing, and trading of modern Chinese medicines. The company's products comprise injection, soft capsule, granule, and others of which injection generates maximum revenue to the company.
---
2877 Stock 12 Month Forecast
Average Price Target
―Technical Analysis
Best Analysts Covering 2877
1 Year
1 Year Success Rate
1/3 ratings generated profit
1 Year Average Return
+0.93%
reiterated a buy rating 3 months ago
Copying Chris Lui's trades and holding each position for 1 Year would result in 33.33% of your transactions generating a profit, with an average return of +0.93% per trade.
---